Graves’ ophtalmopathy
Oftalmopatía de Graves
Satvinder Bakshi
http://dx.doi.org/10.53986/ibjm.2022.0013
Iberoam J Med, vol.4, n2, p.128-130, 2022
Keywords
Graves’ ophtalmopathy; Graves’ disease; Hyperthyroidism
Palabras clave
Oftalmopatía de Graves; Enfermedad de Graves; Hipertiroidismo
References
1. Bahn RS. Current Insights into the Pathogenesis of Graves' Ophthalmopathy. Horm Metab Res. 2015;47(10):773-8. doi: 10.1055/s-0035-1555762.
2. Wiersinga WM. Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy. Lancet Diabetes Endocrinol. 2017;5(2):134-42. doi: 10.1016/S2213-8587(16)30046-8.
3. Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Velázquez-Villoria Á, Galofré JC. Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management. J Ophthalmol. 2015;2015:249125. doi: 10.1155/2015/249125.
Submitted date:
01/19/2022
Reviewed date:
02/24/2022
Accepted date:
02/26/2022
Publication date:
02/26/2022